Top Health Tools
Top Health Tools

Top Reports
Top Reports
Top Articles
Top Articles

Top Reviews
Top Reviews
WHO Attempts To Reassure Skeptical
Public on H1N1 Vaccine Safety Issues

The World Health Organization (WHO) restated its confidence in the H1N1 flu vaccine, calling it the most important tool against the pandemic.

Despite widespread accusations which showed a plethora of contradictions in WHO pandemic statements and policies, the international health agency asserted their position with claims that "mild adverse side effects such as muscle cramps or headache are to be expected in some cases, but everyone who has access to the vaccine should be inoculated."

Mass vaccination campaigns against the swine flu virus are underway in China and Australia and will be starting soon in the United States and parts of Europe, WHO spokesman Gregory Hartl said.

"It is important to remember that the vaccines, which have already been approved, have been used for years and years and years in their seasonal vaccine formulation and have been shown to be among the safest vaccines that exist," he told a news briefing.

The misguided reassurances from WHO are attempting to discredit hundreds of independent and credible investigations which showed that the Center of Disease Control (CDC) and the WHO have been orchestrating the pandemic flu campaign from day one. It is the WHO for "years and years" has been convincing the public that a harmless flu is a greater risk to public health than any vaccine. In actuality, the reverse is true (see the H1N1 vaccine is a much great risk to your health than the flu itself).

Last month, Dr. Leonard G. Horowitz, a world leading drug-industry investigator launched a well-documented investigation and subsequent legal affidavit on the circumstances concerning the evidence and politically explosive issues raised by discoveries into the H1N1 swine flu.

According to the affidavit, the United Nations’ and the WHO are directly involved in the serological testing of vaccine trials; the preparation and distribution of influenza viruses to vaccine manufacturers; and the coordination of EU strain selection process (ie., the selection of viruses that shall be used by governments worldwide, and their “vaccine pipelines.")

Hartl, asked whether WHO was concerned by reports that some people were reluctant to be injected with the new vaccine, said:

"Certainly we have seen the reports. Again, we would restate that the most important tool that we have to fight this pandemic is the vaccine."

It was doubly important that health care workers be vaccinated, as it protects them as well as patients, he added.

"We would hope that everyone who has a chance to get vaccinated does get vaccinated," Hartl told Reuters.

Since late spring, governments around the world have been telling administrators of large facilities such as hospitals, schools and community centres, to prepare for mass vaccination programs set to be instituted in the fall.

The United Nations agency declared in June that the H1N1 virus was causing an influenza pandemic and its collaborating laboratories have provided seed virus to drug makers worldwide to develop vaccines.

GlaxoSmithKline won a further 22 government orders for its H1N1 swine flu vaccine in the last two months, taking the total number of doses ordered to 440 million worth some $3.5 billion. Rivals in flu vaccines include Sanofi-Aventis, Novartis, Baxter, AstraZeneca and CSL.

A full list of h1n1 vaccine ingredients, alerts and warnings from the companies themselves is available here.

Reference Source 89
October 6, 2009

STAY CONNECTEDNewsletter | RSS | Twitter | YouTube |
This site is owned and operated by 1999-2018. All Rights Reserved. All content on this site may be copied, without permission, whether reproduced digitally or in print, provided copyright, reference and source information are intact and use is strictly for not-for-profit purposes. Please review our copyright policy for full details.
volunteerDonateWrite For Us
Stay Connected With Our Newsletter